Birgit Blechert
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- biodegradable polymer synthesis and properties
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
Papers in
-
- Radiopharmaceutical Chemistry and Applications 12
-
- Cancer, Hypoxia, and Metabolism 1
- Co-authors
- Markus Essler (12 shared papers)Florian Christoph Gaertner (8 shared papers)Robert Luxenhofer (1 shared paper)Rainer Jordan (1 shared paper)Christof Seidl (6 shared papers)Klaus‐Peter Janssen (3 shared papers)Frank Bruchertseifer (5 shared papers)Reingard Senekowitsch–Schmidtke (3 shared papers)
- Journals
- European Journal of Nuclear Medicine and Molecular Imaging (3 papers)Journal of Nuclear Medicine (2 papers)Angiogenesis (1 paper)Journal of Controlled Release (1 paper)Molecular Pharmaceutics (1 paper)
- Partner nations
- GermanyBelgiumUnited States
In The Last Decade
Birgit Blechert
16 papers receiving 702 citations
Peers
Comparison fields: 5 of 59
- Biomaterials 138
- Radiology, Nuclear Medicine and Imaging 238
- Surfaces, Coatings and Films 26
- Pharmaceutical Science 28
- Molecular Medicine 24
Countries citing papers authored by Birgit Blechert
This map shows the geographic impact of Birgit Blechert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Blechert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Blechert more than expected).
Fields of papers citing papers by Birgit Blechert
This network shows the impact of papers produced by Birgit Blechert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Blechert. The network helps show where Birgit Blechert may publish in the future.
Co-authors
The 25 scholars most cited alongside Birgit Blechert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 220 | |
| 2 | 2006 | 74 | |
| 3 | 2016 | 70 | |
| 4 | 2012 | 65 | |
| 5 | 2009 | 52 | |
| 6 | 2009 | 46 | |
| 7 | 2014 | 44 | |
| 8 | Effects of topoisomerase inhibitors that induce DNA damage response on glucose metabolism and PI3K/Akt/mTOR signaling in multiple myeloma cells. | 2015 | 36 |
| 9 | 2006 | 34 | |
| 10 | 2016 | 22 | |
| 11 | 2016 | 18 | |
| 12 | 2012 | 17 | |
| 13 | 2009 | 11 | |
| 14 | 2013 | 8 | |
| 15 | 2023 | 3 | |
| 16 | Probenecid reduces renal uptake of 111In-DOTATOC in rats | 2006 | 1 |
About Birgit Blechert
Birgit Blechert is a scholar working on Radiology, Nuclear Medicine and Imaging, Cancer Research, Endocrinology, Diabetes and Metabolism, Oncology and Physiology, having authored 16 papers that have together received 721 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (12 papers), Cancer, Hypoxia, and Metabolism (1 paper), PI3K/AKT/mTOR signaling in cancer (1 paper), Alzheimer's disease research and treatments (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Cytokine Signaling Pathways and Interactions (1 paper), Neuroendocrine Tumor Research Advances (1 paper) and Thyroid Cancer Diagnosis and Treatment (1 paper). The work is most often cited by research in Biomaterials (138 citations), Radiology, Nuclear Medicine and Imaging (238 citations), Surfaces, Coatings and Films (26 citations), Pharmaceutical Science (28 citations) and Molecular Medicine (24 citations). Birgit Blechert has collaborated with scholars based in Germany, Belgium and United States. Frequent co-authors include Markus Essler, Florian Christoph Gaertner, Robert Luxenhofer, Rainer Jordan, Christof Seidl, Klaus‐Peter Janssen, Frank Bruchertseifer, Reingard Senekowitsch–Schmidtke, Markus Schwaiger and Georg F. Weber. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Journal of Nuclear Medicine, Angiogenesis, Journal of Controlled Release and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.